VA
ZURA icon

VR Adviser’s Zura Bio ZURA Stock Holding History

VR Adviser’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38M Hold
6,434,990
– – 1.15% 18
2026
Q1 		$38.3M Buy
6,434,990
+1,089,875
+20% +$6.58M 1.43% 20
2025
Q4 		$28M Buy
5,345,115
+713,899
+15% +$2.82M 1.38% 20
2025
Q3 		$20.1M Hold
4,631,216
– – 1.13% 23
2025
Q2 		$4.86M Sell
4,631,216
-391,950
-8% -$469K 0.36% 28
2025
Q1 		$6.48M Buy
5,023,166
+3,000,000
+148% +$4.73M 0.55% 26
2024
Q4 		$5.06M Hold
2,023,166
– – 0.35% 31
2024
Q3 		$8.21M Sell
2,023,166
-4,000,000
-66% -$14.9M 0.43% 32
2024
Q2 		$21.1M Buy
+6,023,166
New +$24.6M 1.34% 23

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return

VR Adviser's ZURA Position: Q2 2026 in Review

VR Adviser held its Zura Bio (ZURA) position steady in Q2 2026 at 6,434,990 shares worth $38M. The position accounts for 1.15% of the portfolio, ranked #18.

VR Adviser first reported a position in ZURA in Q2 2024 and has held it in 9 quarters since. The position peaked at $38.3M in Q1 2026. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • VR Adviser held 6,434,990 shares of Zura Bio worth $38M as of Q2 2026.
  • VR Adviser left its Zura Bio share count unchanged in Q2 2026.
  • Zura Bio made up 1.15% of VR Adviser's portfolio in Q2 2026, its #18 holding.
  • VR Adviser first reported a position in Zura Bio in Q2 2024 and has held it in 9 quarters since.
  • VR Adviser's Zura Bio position peaked at $38.3M in Q1 2026.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on VR Adviser's 13F filing for Q2 2026, filed 14 Aug 2026.